AU471618B2 - Psychopharma cologically active peptides - Google Patents

Psychopharma cologically active peptides

Info

Publication number
AU471618B2
AU471618B2 AU52511/73A AU5251173A AU471618B2 AU 471618 B2 AU471618 B2 AU 471618B2 AU 52511/73 A AU52511/73 A AU 52511/73A AU 5251173 A AU5251173 A AU 5251173A AU 471618 B2 AU471618 B2 AU 471618B2
Authority
AU
Australia
Prior art keywords
psychopharma
active peptides
cologically active
cologically
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU52511/73A
Other versions
AU5251173A (en
Inventor
Marie Greven Hendrik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of AU5251173A publication Critical patent/AU5251173A/en
Application granted granted Critical
Publication of AU471618B2 publication Critical patent/AU471618B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU52511/73A 1972-03-08 1973-02-22 Psychopharma cologically active peptides Expired AU471618B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NLNL72.03042 1972-03-08
NL7203042A NL7203042A (en) 1972-03-08 1972-03-08

Publications (2)

Publication Number Publication Date
AU5251173A AU5251173A (en) 1974-08-22
AU471618B2 true AU471618B2 (en) 1976-04-29

Family

ID=19815540

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52511/73A Expired AU471618B2 (en) 1972-03-08 1973-02-22 Psychopharma cologically active peptides

Country Status (12)

Country Link
JP (1) JPS48103575A (en)
AU (1) AU471618B2 (en)
BE (1) BE796478A (en)
CA (1) CA1025439A (en)
CH (1) CH584681A5 (en)
DE (1) DE2311099A1 (en)
FR (1) FR2181803B1 (en)
GB (1) GB1425099A (en)
HU (1) HU169157B (en)
NL (1) NL7203042A (en)
SE (1) SE406761B (en)
ZA (1) ZA731207B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587233A (en) * 1983-11-07 1986-05-06 Board Of Trustees Of The Leland Stanford Junior University Use of Arg-Phe-amide derivatives
WO2011133348A1 (en) * 2010-04-21 2011-10-27 Pharmacofore, Inc. Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1301738A (en) * 1969-07-09 1973-01-04

Also Published As

Publication number Publication date
NL7203042A (en) 1973-09-11
CH584681A5 (en) 1977-02-15
JPS48103575A (en) 1973-12-25
GB1425099A (en) 1976-02-18
HU169157B (en) 1976-10-28
DE2311099A1 (en) 1973-09-13
SE406761B (en) 1979-02-26
ZA731207B (en) 1973-11-28
FR2181803B1 (en) 1976-09-03
AU5251173A (en) 1974-08-22
BE796478A (en) 1973-09-10
CA1025439A (en) 1978-01-31
FR2181803A1 (en) 1973-12-07

Similar Documents

Publication Publication Date Title
CA975240A (en) Tent
CA1025440A (en) Psychopharmacologically active peptides
CA1030953A (en) Psychopharmacologically active peptides
AU465548B2 (en) Psychopharmacological peptides
AU471401B2 (en) Sedative peptides
AU470908B2 (en) Psychopharmacologically active peptides
CA976551A (en) Hydroxyguanidine o-carbamates
AU471618B2 (en) Psychopharma cologically active peptides
CA988764A (en) Processor
AU4950372A (en) Tent
CA1010022A (en) Psychopharmacological peptides
AU481531B2 (en) Therapeutically active aryldiamides
CA914157A (en) Peptides
AU5203473A (en) Therapeutically active aryldiamides
CA902050A (en) Adamantylalkylaminoalkyl benzamides
CA908171A (en) Herbicidally active perfluoroalkylsulfonamides
AU470906B2 (en) Psychopharmacological peptides
AU491757B2 (en) Aspirin-tea coprecipitates
CA909677A (en) Therapeutically active composition
AU3935172A (en) Tripeptide
CA906656A (en) Active memory
CA898778A (en) Structures
CA914354A (en) Inorganic-organo titanates
AU474814B2 (en) Improved sprinkler
CA892597A (en) Ethyl 6-alkoxy-7-(r1-oxymethyl)-4-hydroxy-3-quinolinecarboxylates